Top Banner
DR. BHUPUTRA PANDA MATERNAL & CHILD HEALTH: SCENARIO AND LESSONS LEARNED FROM BOLANGIR, ODISHA
21

Maternal & child health bolangir

Jun 14, 2015

Download

Healthcare

Bhuputra Panda

Status of maternal and child health programmes in Bolangir, Odisha
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Maternal & child health bolangir

D R. B H U P U T RA PA N DA

MATERNAL & CHILD HEALTH: SCENARIO AND LESSONS LEARNED FROM

BOLANGIR, ODISHA

Page 2: Maternal & child health bolangir

BOLANGIR

Page 3: Maternal & child health bolangir

ABOUT BOLANGIR

• Geographical Area: 6575 sq. kms.

• Population: 1,648,997 

• Child Population (0 to 6 yrs.):  216,320

• About 88% of population live in rural area

Page 4: Maternal & child health bolangir

MATERNAL HEALTH STATUS

• Mothers who received 3 or more ANC: 83.8%

• Mothers who have received at least one TT injection: 99.2%

• Mothers who have consumed IFA for 100 days or more: 23.8%

• Institutional Delivery: 80.1%

• Mothers who have received PNC after 48 hrs of delivery: 86.5%

• Maternal Mortality Ratio: 234

Page 5: Maternal & child health bolangir

CHILD HEALH STATUS

• Full Immunization: 79.5%

• Neonatal Mortality Rate: 71

• Infant Mortality Rate: 97

• Under Five Mortality Rate: 111

Page 6: Maternal & child health bolangir

PREVIOUS AND ONGOING INTERVENTIONS BY PHFI-UNICEF

• Assessment of Supportive Supervision strategy of Routine Immunization in Odisha-A randomized post-test study, 2011-12

• ToT to about 175 master trainers across the state on IMNCI basic health worker and follow up supervision, 2012-13

• Evidence based IMNCI, RI, and VHND service delivery through health system strengthening-an external monitoring demonstration project, PHFI, Ongoing project

Page 7: Maternal & child health bolangir

• 8 of 14 blocks in the district were identified as sample blocks based on WHO 30 cluster sampling

• Baseline survey was completed in July and August 2013 to assess the existing practices in RI, VHND and IMNCI

• Standard RI, VHND and IMNCI supervision checklists were used for data collection

• Data analysis was done using SPSS statistical software to analyze the data of baseline and every quarter

ABOUT ONGOING INTERVENTION

Page 8: Maternal & child health bolangir

INTERVENTION PACKAGE

• Extensive field visits to RI, VHND and IMNCI sessions accompanied by internal monitors

• Hand-holding support provided to supervisors provided on site on supportive supervision

• Capacity building of front line health workers and supervisors

• Techno-managerial support for quality improvement of the programmes

• Advocacy at district and sub district levels for convergence and health systems strengthening

Page 9: Maternal & child health bolangir

PROGRESSIVE OUTPUT OF INTERVENTION

• One year of intervention has been planned, of which we are currently in the last quarter

• Data from the field is analyzed every quarter

• Trend from the analysis is reflected in the following slides

Page 10: Maternal & child health bolangir

FROM ROUTINE IMMUNIZATION

Basel

ine

(N=32

)

1st Q

uarte

r (N=

8)

2nd

Quarte

r (N=

8)

3rd

Quarte

r (N=

9)88

92

96

10098

96

92

100

Vaccine Availability

In %

Basel

ine

(N=32

)

1st Q

uarte

r (N=

8)

2nd

Quarte

r (N=

8)

3rd

Quarte

r (N=

9)0

40

80 99 100

100 100Availability of Syringes

In %

Basel

ine

(N=32

)

1st Q

uarte

r (N=

8)

2nd

Quarte

r (N=

8)

3rd

Quarte

r (N=

9)0

40

8063 63

82 78

Availability of MCP Cards

In %

Basel

ine

(N=32

)

1st Q

uarte

r (N=

8)

2nd

Quarte

r (N=

8)

3rd

Quarte

r (N=

9)0

40

8098 100

6389

Availability of Drugs

In %

Page 11: Maternal & child health bolangir

Baseline (N=32)

1st Quarter (N=8)

2nd Quarter (N=8)

3rd Quarter (N=9)

0

20

40

60

80

100

72

25 25

67

Availability of Counterfoils

In %

04080 81

63 5088

Availability of functional hub cutter

In %

Baseline (N=32)

1st Quarter (N=8)

2nd Quarter (N=8)

3rd Quarter (N=9)

0

20

40

60

80

100

47

100

50

78

Use of Tally Sheet

In %

Baselin

e (N

=32)

1st Q

uarte

r (N=

8)

2nd Quar

ter (

N=8)

3rd Q

uarte

r (N=

9)0

40

80100

63 5078

Cutting syringe after use

In %

FROM ROUTINE IMMUNIZATION

Page 12: Maternal & child health bolangir

FROM ROUTINE IMMUNIZATION

Baseline (N=32)

1st Quarter (N=8)

2nd Quarter (N=8)

3rd Quarter (N=9)

0

20

40

60

80

100

50 5063

78

AVD Implementation

In %

Baselin

e (N

=32)

1st Q

uarte

r (N=

8)

2nd Quar

ter (

N=8)

3rd Q

uarte

r (N=

9)0

40

80 81 75 88 89

Segregation at Source

In %

Baseline (N=32)

1st Quarter (N=8)

2nd Quarter (N=8)

3rd Quarter (N=9)

0

20

40

60

80

10081

1338

78

Delivery of 4 key messages

In %

04080

3125 50

89

Asking beneficiaries to wait 30 mins

In %

Page 13: Maternal & child health bolangir

FROM VHND

0

40

80 75 8161

82

Presence of Health Supervisor

In % 0

4080

11

52 6282

Session Site (Anganwadi Centre)

In %

Baselin

e (N

=32)

1st Q

uarte

r (N=

21)

2nd Quar

ter (

N=13)

3rd Q

uarte

r (N=

17)0

4080 66 47 62 70

Availability of Examination Table

In %

04080

31 22 31 35

Availability of screens for Privacy

In %

Page 14: Maternal & child health bolangir

FROM VHND

Baselin

e (N

=32)

1st Q

uarte

r (N=

21)

2nd Quar

ter (

N=13)

3rd Q

uarte

r (N=

17)0

40

80 73 5683 78

Availability of Diagnostic Equipment

In %

Baseline (N=32)

1st Quarter (N=21)

2nd Quarter (N=13)

3rd Quarter (N=17)

020406080

100

71

45

7963

Availability of Drugs

In %

Baseline (N=32)

1st Quarter (N=21)

2nd Quarter (N=13)

3rd Quarter (N=17)

0

20

40

60

80

100

37

63 64 65

Relevant History Taken

In %

Baseline (N=32)

1st Quarter (N=21)

2nd Quarter (N=13)

3rd Quarter (N=17)

020406080

100

72

38

6276

Abdominal Palpation Done and Recorded

In %

Page 15: Maternal & child health bolangir

FROM VHND

04080

1247 54

71

Urine Examination Done and Recorded

In %

04080

37 38 50 53

Privacy Ensured During Exam-ination

In %

Baselin

e (N

=32)

1st Q

uarte

r (N=

21)

2nd Quar

ter (

N=13)

3rd Q

uarte

r (N=

17)0

40

8065 54

77 66

Counseling

In %

Baseline (N=32)

1st Quarter (N=21)

2nd Quarter (N=13)

3rd Quarter (N=17)

020406080

10081

5369

53

Group meeting conducted with Women

In %

Page 16: Maternal & child health bolangir

FROM VHND

Baseline (N=32)

1st Quarter (N=21)

2nd Quarter (N=13)

3rd Quarter (N=17)

0102030405060708090

100

56 5261 57

Availability of Contraceptives

In %

Baseline (N=32)

1st Quarter (N=21)

2nd Quarter (N=13)

3rd Quarter (N=17)

0102030405060708090

100

78

28

9282

Family Planning Counseling

In %

Page 17: Maternal & child health bolangir

FROM IMNCI

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

0

20

40

60

80

100

12

28 3954

Home visits as per IMNCI guidelines

In %

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

0

20

40

60

80

100

25

3439

50

IMNCI assessment sheets filled up

In %

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

0

20

40

60

80

100

2731

28

46

IMNCI monthly reporting done

In %

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

020406080

100

35

4747

56

Skill of worker for 0 to 2 months children

In %

Page 18: Maternal & child health bolangir

FROM IMNCI

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

020406080

100

28

3540

56

Skill of worker for 2 months – 5 year children

In %

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

0

20

40

60

80

100

53

6 8

Availability of IMNCI Board

In %

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

0

20

40

60

80

100

5458

61

34

Availability of Drugs

In %

Baseline (N=64)

1st Quarter (N=29)

2nd Quarter (N=18)

3rd Quarter (N=24)

75

80

85

90

95

100

85

96

9492

Availability of Forms and Formats

In %

Page 19: Maternal & child health bolangir

SUMMARY OF INDICATORS  Continuously Improving Fluctuating Not Improving

RI

• Vaccine availability at session site • Availability of MCP Cards • AVD Implementation

• Availability of syringes and drugs • Use of counterfoil  

• Delivery of 4 key messages • Waste Disposal  • Asking beneficiaries to wait for 30

mins after vaccination   

• Availability of hub cutter    • Visit of health supervisor    • Use of Tally Sheet    

VHND

• Visit of health supervisor• Availability of VHND

drugs• Group meeting with men

• Availability of examination table and screens

• Ensuring privacy • Visit of ICDS supervisors

• Availability of other essential logistics

• Counseling of beneficiaries

• Participation of PRI Members

• Implementation of VHND Duelist• Group meeting with

women 

• Relevant history taking prior to 1st ANC

   

• Recording fetal heart sound    • Abdominal palpation    

IMNCI

• Home visits• Availability of IMNCI

drugs • Availability of IMNCI Board

• Filling up of assessment sheets• Availability of other

support logistics 

• Monthly reporting    • Skills of workers    

Page 20: Maternal & child health bolangir

WAY FORWARD

• To conduct an end line survey in the month of October and evaluate the output of the project intervention

• Scale up the best practices and replicate the model across the state for health systems strengthening

Page 21: Maternal & child health bolangir

THANK YOU